Detalhe da pesquisa
1.
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis.
N Engl J Med
; 387(25): 2317-2330, 2022 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546624
2.
A physiologically required G protein-coupled receptor (GPCR)-regulator of G protein signaling (RGS) interaction that compartmentalizes RGS activity.
J Biol Chem
; 288(38): 27327-27342, 2013 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23900842
3.
The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: a systematic review and meta-analysis.
AIDS Care
; 25(4): 400-14, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-22908886
4.
Validation of the novel Eosinophilic Esophagitis Impact Questionnaire.
J Patient Rep Outcomes
; 7(1): 120, 2023 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38010430
5.
Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Gastroenterol Hepatol
; 8(11): 990-1004, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37660704
6.
Antibacterial data synthesis challenges: a systematic review of treatments for complicated Gram-negative urinary tract infections.
J Comp Eff Res
; 10(18): 1385-1400, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34672210
7.
Complicated carbapenem-resistant infections: a treatment pathway analysis in Italian sites.
Infez Med
; 29(3): 434-449, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35146349
8.
Burden of carbapenem non-susceptible infections in high-risk patients: systematic literature review and meta-analysis.
Antimicrob Resist Infect Control
; 9(1): 193, 2020 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33287894
9.
Attributable burden in patients with carbapenem-nonsusceptible gram-negative respiratory infections.
PLoS One
; 15(2): e0229393, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32084236
10.
Contributing Factors to the Clinical and Economic Burden of Patients with Laboratory-Confirmed Carbapenem-Nonsusceptible Gram-Negative Respiratory Infections.
Infect Drug Resist
; 13: 761-771, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32210590
11.
Contributing Factors to the Clinical and Economic Burden of Patients with Laboratory-Confirmed Carbapenem-Nonsusceptible Gram-Negative Urinary Tract Infections.
Clinicoecon Outcomes Res
; 12: 191-200, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32308447
12.
Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland.
Rheumatol Ther
; 5(1): 57-73, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29633197
13.
Carbapenem-Nonsusceptible Gram-Negative Pathogens in ICU and Non-ICU Settings in US Hospitals in 2017: A Multicenter Study.
Open Forum Infect Dis
; 5(10): ofy241, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30364442
14.
Dose Escalation and Healthcare Resource Use among Ulcerative Colitis Patients Treated with Adalimumab in English Hospitals: An Analysis of Real-World Data.
PLoS One
; 11(2): e0149692, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26919745